Canopy Growth (CGC) Accounts Payables (2017 - 2026)
Canopy Growth (CGC) posted Accounts Payables of $25.4 million for Q1 2026, up 77.36% sequentially from $14.3 million in Q4 2025, and up 39.58% YoY from $18.2 million in Q1 2025.
Canopy Growth (CGC) Accounts Payables (2017 - 2026) Analysis & Trends
Canopy Growth has reported Accounts Payables for 10 years, with the latest figure at $25.4 million in Q1 2026.
- Quarterly Accounts Payables rose 39.58% year-over-year to $25.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.4 million (up 39.58% YoY) and the FY2026 annual result came in at $25.4 million, up 39.58% from the prior year.
- Accounts Payables rose to $25.4 million in Q1 2026 per CGC's latest filing, from $14.3 million in the prior quarter.
- Over five years, Accounts Payables peaked at $52.3 million in Q3 2022 and troughed at $13.2 million in Q3 2025.
- A 5-year average of $27.4 million and a median of $20.7 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2026: Accounts Payables slumped 67.59% in 2023, then jumped 39.58% in 2026.
- Over 5 years, Accounts Payables stood at $46.5 million in 2022, then sank by 59.2% to $19.0 million in 2023, then advanced by 9.08% to $20.7 million in 2024, then plunged by 30.85% to $14.3 million in 2025, then soared by 77.36% to $25.4 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $25.4 million, $14.3 million, and $13.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Canopy Growth | 449.71 Mn | 202.70 Mn | 16.08 Mn | 20.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.68 Mn |
| Mar 31, 2026 | 25.39 Mn |
| Dec 31, 2025 | 14.32 Mn |
| Sep 30, 2025 | 13.18 Mn |
| Jun 30, 2025 | 17.38 Mn |
| Mar 31, 2025 | 18.19 Mn |
| Dec 31, 2024 | 20.70 Mn |
| Sep 30, 2024 | 13.46 Mn |
| Jun 30, 2024 | 18.64 Mn |
| Mar 31, 2024 | 21.28 Mn |
| Dec 31, 2023 | 18.98 Mn |
| Sep 30, 2023 | 16.95 Mn |
| Jun 30, 2023 | 42.85 Mn |
| Mar 31, 2023 | 23.55 Mn |
| Dec 31, 2022 | 46.51 Mn |
| Sep 30, 2022 | 52.29 Mn |
| Jun 30, 2022 | 50.71 Mn |
| Mar 31, 2022 | 50.74 Mn |
| Dec 31, 2021 | 53.82 Mn |
| Sep 30, 2021 | 74.97 Mn |